Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury

NCT05951777 is registered in ClinicalTrials.gov with Hope Biosciences LLC as lead sponsor.

NCT NCT05951777
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05951777 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury
Lead sponsor
Hope Biosciences LLC
Phase
Phase 2
Overall status
Recruiting
Start date
April 16, 2024
Completion date
December 31, 2027
Enrollment
51 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

traumatic brain injury